Your skepticism about the price we bought the MS diagnostic is understandable. If it can bring in so much revenue, why were we able to get it so cheaply? I think it is because they valued the AMBS shares we are giving them. They know those shares will be substantially higher in a couple of years. To figure out the true price we paid to get the MS diagnostic, you have to look into our future of MANF and Eltoprazine.

I think Gerald helped them see that.....and they bought into it.